PerkinElmer Recognizes Gas Chromatography Innovation at PITTCON 2005

PerkinElmer Recognizes Gas Chromatography Innovation at PITTCON 2005

    Business Editors/Health/Medical Writers
    Pittcon 2005

    ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 28, 2005--PerkinElmer Inc. (NYSE: PKI):

--	Celebrates 50th Anniversary of GC Innovation
--	Introduces New Application-based Solutions and Product Enhancements that Increase Speed and Productivity

    PerkinElmer Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, today announced that it will showcase industry-leading products and solutions at the annual Pittsburgh Conference (PITTCON) at the Orange County Convention Center in Orlando, Florida, Booth 4728.
    Among the products being shown are two new gas chromatography (GC) systems: the PerkinElmer-Arnel(TM) TOGA (transformer oil and gas analyzer) system, integrated with PerkinElmer's TurboMatrix(TM) Headspace Sampler, for the analysis of transformer oil fault gases; and a system featuring the PerkinElmer TurboMatrix Headspace Trap for the analysis of off-flavor components in beer. Both systems provide enhanced analysis while meeting industry standards and specifications.
    During the show, PerkinElmer will celebrate the 50th anniversary of its GC technology by highlighting many of the "firsts" that PerkinElmer has achieved in product innovation over the past five decades.
    PerkinElmer's booth will also showcase significant enhancements to the company's ELAN(R) line of ICP-MS instrumentation. These include a simplified new design, an application-specific software package called Chromera(TM) that efficiently combines all components of a speciation measurement system, and ELAN Enhanced Security software for 21 CFR Part 11 compliance.
    Another highlight is the LABWORKS(TM) LIMS Online Administrator, which provides secure browser-based access for reviewing test information, results and reports.
    Peter B. Coggins, Ph.D., president of PerkinElmer LAS, is a featured speaker at the American Chemical Society/Centcom Ltd. 27th Annual Breakfast, held at PITTCON on March 1.
    "We are constantly motivated by our customers to develop powerful, integrated solutions of software, instruments and service that meet their needs," said Coggins. "PITTCON remains an important venue for connecting with customers and introducing market-driven solutions that will enhance their productivity and efficiency and accelerate their time to market for new products."

    Other PITTCON highlights from PerkinElmer include:

    -- The announcement of a new collaboration with Malvern
    Instruments, a leading supplier of analytical solutions for
    particle characterization, to offer customers in North America
    a complete solution for their rheology and thermal analysis
    needs.

    -- TurboMass 5.1 software enhancements that streamline set-up and
    ensure correct peak integration and identification through a
    rapid review process.

    -- PerkinElmer Universal Reflectance Accessory (URA), a
    breakthrough sampling accessory for absolute reflectance
    measurements at variable angles. The URA automates angle
    changes, eliminates alignment issues, and permits instant
    switching between reference and sample.

    -- PerkinElmer LAMBDA(TM) 950, 850 and 650 UV/Vis/NIR and UV/Vis
    spectrophotometers, the industry standard for high
    performance, flexibility and convenience. Each model includes
    the same range of modular components and snap-in accessories
    to tackle a range of tough applications.

    -- PerkinElmer Spectrum(TM) Spotlight(TM) 200 FTIR microscope
    system, a fully automated, fully upgradeable, high performance
    microscopy platform. This revolutionary system enables quick,
    easy collection of high sample quality data, while in-field
    upgrade to a full imaging system minimizes downtime and
    extends IR analysis to new applications.

    -- New 6.3 version of PerkinElmer TotalChrom(R) Chromatography
    Data System, which brings a new level of performance and
    increased productivity coupled with ease-of-use and
    flexibility for fast-paced, high-throughput, high-volume data
    reporting laboratories.

    Factors Affecting Future Performance

    This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions are intended to identify forward-looking statements. There are a number of important risk factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including risks related to cyclical downturns affecting several of the industries into which we sell our products, our failure to introduce new products in a timely manner, the impact of our debt on our cash flow and investment opportunities, our ability to comply with financial covenants contained in our credit agreements and debt instruments, risks related to our international operations, our ability to adjust our operations to address unexpected changes, our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business, the loss of any of our licenses that may require us to stop selling products or lose competitive advantage, competition, regulatory changes, our failure to obtain and enforce intellectual property protection, our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets, as well as other factors which we describe under the caption "Forward-Looking Information and Factors Affecting Future Performance" in our most recently filed annual report on Form 10-K and in our most recently filed quarterly report on Form 10-Q. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

    PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers' needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

--30--SP/bo*

CONTACT: Investor Contact: PerkinElmer, Inc. Dan Sutherby, 781-431-4306 or Media Contact: Brodeur Worldwide Karen McManus, 617-587-2860

KEYWORD: MASSACHUSETTS FLORIDA TRACK INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY TRADESHOW SOURCE: PerkinElmer, Inc.

Copyright Business Wire 2005